Page 18 - 81_02
P. 18
Problems associated with the emission of pharmaceutical products to the environment
Sorokin M., Nolan M, Tyler CR, van Aerle R., Santos, 127. Carballa M, Oimil F, Lema JM, Llompart M., Jarcia-
EM y Brighty G. Predicted exposures to steroid Jares C, Rodriguez I, Gomez M y Ternes T. Behaviour of
oestrogens in UK rivers correlate with widespread sexual pharmaceuticals , cosmetics and hormones in a sewage
disruption in wild roach poblations. Environm. Health treatment plant. Water Res. 2004; 38: 2918-2926.
Perspect, 2006; 114 (suppl. 1): 32-39.
128. Zabczynski S, Buntner D, Miksch K y Roig B.
114. Tyler CR y Jobling S. Roach, sex, and gender- Performance of conventional treatment processes of the
bending chemicals: the feminization of wild fish in English most resistant PPs. En: Roig B, Ed. Pharmaceuticals in the
rivers. Bioscience. 2008; 58: 1051-1059. Environment . AGA Pub. Londres, 2010.
115, Caldwell DJ et al. Derivation of an aquatic predicted 129. BIO Intelligence Service. Study on the Environmentl
no-effect concentration for the synthetic hormone 17a- risks of medicinal products. . Executive Agency for Health
ethilynstradiol. Env, Sci. Technol. 2008; 42,19:7046-7054. and Consumers. Paris 2013.
116. Nash JP, Kime DE, van der Ven LT, Wester PW, 130. FASS (Sewdish Medicines Compendium).
Brion F, Maack G, Stahlschmidt-Allner P. y Tyler CR. Environmental classification of pharmaceuticals.
Long-term exposure to environmental concentrations of Disponible en: (www.fass.se Guidance for
the pharmaceutical ethinyloestradiol cause reproductive pharmaceuticals companies. 2007).
failure in fish. Environm. Health Perspect. 2004; 112:
1725-1733. 131. Cabrejas JM y González D. Los residuos
farmacéuticos. En: Los residuos y sus riesgos para la
117. Santos LH, Araújo AN, Fachini A, Pena A., Delerue- salud. Madrid: Real Academia de Farmacia 2009; pp. 229-
Martos C. y Montenegro MC Ecotoxicological aspects 240.
related to the presence of pharmaceuticals in the aquatic
environment. Jour. Harzard.Material. 2010; 175: 45-95. 132. Kümmerer K. Sustainable from the very beginning:
rational design of molecules by life cycle for green
118. Santos, LH, Araújo AN, Fachini A, Pena A., Delerue- engineering as an important approach for green pharmacy
Martos C. y Montenegro MC Ecotoxicological aspects and green chemistry. Green Chem. 2007; 9: 899-907.
related to the presence of pharmaceuticals in the aquatic
environment. Jour. Harzard.Material. 2010; 175: 45-95. 133. Daughton CG. “Cradle-to-cradle” Stewardship of
Drugs for Minimizing Their Environmental Disposition
119. Boxall A. y Greenwood R. Biological monitoring and while Promoting Human Health. I. Ratonales for and
edndpoints. En: Roig B. Ed. Pharmaceuticals in the Avenues toward a Green Pharmacy. Environm. Health
Environment. AWA Pub. Londres, 2010. Perspect. 2003; 111: 757-774.
120. Santos LH, Araújo AN, Fachini A, Pena A, Delerue- 134. Kümmerer K y Hempel M. (eds.) Green and
Martos C. y Montenegro MC. Ecotoxicological aspects Sustainable Pharmacy. Springer-Verlag. Berlin 2010.
related to the presence of pharmaceuticals in the aquatic
environment. Jour. Harzard.Material. 2010; 175: 45-95. 135. Organización Mundial de la Salud (OMS).
Perspectivas políticas de la OMS sobre medicamentos.
121. Ankley GT, Brooks BW, Huggett DB y Sumpter JP. Ginebra, 2004.
Repeating History: Pharmaceuticals in the Environment.
Environm. Sci. Tecnol. Dec. 15, 2007: 8211-8217. 136. Kummerer K. y Velo G. Ecopharmacology: A New
Topic of Importance in Pharmacovigilance. Drug Safety,
122. Garcia Galan J, Díaz-Cruz MS y Barceló, D. 2006; 29, 5: 371-373.
Combining chemical analysis and ecotoxitcity to
determine environmental exposure and to assess risk from 137. Daughton CG y Ruhoy IS. Environmental Footprint
sulfonamides. Trends Anal. Chem.2009 ;28, 6: 804-819. of Pharmaceuticals- The Significance of Factors Beyond
Direct Excrection to Sewers. Environm. Toxicol. Chem.
123. Santos JL, Aparicio I y Alonso E. Ocurrence and risk 2009; 28, 12: 2495-2521.
assessment of pharmacutally active compounds in
wasterwater treatment plants. A case study: Sevilla city 138. Daughton CG y Ruhoy IS. Environmental Footprint
(Spain). Environm. International, 2007; 33: 596-601. of Pharmaceuticals- The Significance of Factors Beyond
Direct Excrection to Sewers. Environm. Toxicol. Chem.
124. Camacho-Muñoz D, Martin J, Santos JL, Aparicio I y 2009;28, 12: 2495-2521.
Alonso E. Ocurrence, temporal evolution and risk
assessment of pharmaceutically active compounds in 139. European Medicines Agency (EMA). VICH GL 38
Doñana Park (Spain). Jour. Hazardous Materials 2010; (Ecotoxicity Phase II), Guideline on Environmental Impact
183: 602-608. Assessment for Veterinary Pharmaceuticals-Phase II
(CVMP/VICH/790/03-Final. Londres, 2004.
125. Vazquez-Roig P. Andreu V., Blasco C y Picó, Y.
Risk assessment on the presence of pharmaceuticals in 140. Union Europea. Regulation (CE) No. 1907/2006 of
sediments, soils and waters of the Pego-Oliva Marshlands the European Parlamient and the Council of 18 December
(Valencia, eastern Spain). Sci. Total Environm. 2012; 440: 2006 concerning the Registration, Evaluation,
24-32. Authorisation and Restriction of Chemicals (REACH).
Luxemburgo. 2006.
126. Kümmerer K. Sustainable from the very beginning:
rational design of molecules by life cycle for green 141. Umwelt Bundesamt, (version española) Fármacos en
engineering as an important approach for green pharmacy el medio ambiente – la perspectiva global. Incidencia,
and green chemistry. Green Chem. 2007; 9: 899-907. efectos y acción cooperativa potencial bajo el SAICM.
@Real Academia Nacional de Farmacia. Spain 101
